Images are for illustrative purposes only.
Vesugen
Vesugen is the tripeptide Lys-Glu-Asp (KED), molecular weight approximately 390 Da, developed from research involving vascular tissue-derived peptide fractions. It is the vascular member of the Khavinson bioregulator series, proposed to modulate gene expression in vascular endothelial cells, the cell layer lining blood vessel walls.
Vesugen is structurally notable for a reason worth knowing before ordering: its KED sequence is identical to that of Testagen, the testicular-oriented peptide from the same series. The two are the same molecule described for different tissues, which is a recognized open question for the organ-specificity hypothesis underpinning the class. KED is also the core that Livagen (KEDA), Pancreagen (KEDW), and Prostamax (KEDP) extend by one residue. In vitro and animal studies examine endothelial-cell function, vessel-wall integrity signaling, and microcirculation modeling.
Supplied as a lyophilized 10-vial 20mg kit for in vitro research use only.